We are preparing the requested document. Please wait, this may take a while...!
|Application / Reactivity||Human|
|Activation (Act)||3 Antibodies|
|Apoptosis Blocking (AB)||3 Antibodies|
|Apoptosis Induction (AI)||2 Antibodies|
|Biochemical Assay (BCA)||1 Antibodies|
|Blocking Antibody (Inhibition)||5 Antibodies|
|Blocking Reagent (BR)||1 Antibodies|
|Dot Blot (DB)||13 Antibodies|
|ELISA (Capture)||1 Antibodies|
|Enzyme Immunoassay (EIA)||12 Antibodies|
|Flow Cytometry (FACS)||328 Antibodies|
|Fluorescence Microscopy (FM)||1 Antibodies|
|Functional Studies (Func)||50 Antibodies|
|Immunochromatography (IC)||4 Antibodies|
|Immunocytochemistry (ICC)||14 Antibodies|
|Immunofluorescence (IF)||49 Antibodies|
|Immunofluorescence (Paraffin-embedded Sections) (IF (p))||33 Antibodies|
|Immunohistochemistry (IHC)||130 Antibodies|
|Antigen||Fas (TNF Receptor Superfamily, Member 6) (FAS) Antibodies|
|Conjugate||This FAS antibody is un-conjugated Alternatives|
Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
|6 references available|
|Supplier||Log in to see|
Product Details anti-FAS AntibodyTarget Details FAS Application Details Handling References for anti-FAS Antibody (ABIN238438) Images
|Specificity||The antibody LT95 reacts with CD95 (Fas/APO-1), a 46 kDa single chain type I glycoprotein of the tumour necrosis factor/nerve growth factor (TNF/NGF) receptor superfamily, expressed on a variety of normal and neoplastic cells. It seems that the antibody LT95 does not induce Fas mediated apoptosis, although it cross-blocks anti-Fas DX2 antibody that recognizes a functional epitope of Fas molecule.|
|Cross-Reactivity (Details)||Species reactivity (tested):Human.|
|Characteristics||Synonyms: FASLG receptor, Apo-1 antigen, APT1, FAS1, TNFRSF6, Tumor necrosis factor receptorsuperfamily member 6|
|Purification||Precipitation methods and Ion exchange chromatography.|
|Immunogen||HUT-78 human T cell lymphoma cell line|
Target Details FASProduct Details anti-FAS Antibody Application Details Handling References for anti-FAS Antibody (ABIN238438) Images back to top
|Alternative Name||CD95 / FAS (FAS Antibody Abstract)|
|Background||CD95 (Fas, APO-1), a 46 kDa transmembrane glycoprotein, is a cell death receptor of the TNFR superfamily. Stimulation of CD95 results in aggregation of its intracellular death domains, formation of the death-inducing signaling complex (DISC) and activation of caspases. In type I cells caspase 3 is activated by high amounts of caspase 8 generated at the DISC, in type II cells low concentration of caspase 8 activates pathway leading to the release of cytochrome c from mitochondria and activation of caspase 3 by cytochom c. Besides its roles in induction of apoptosis, Fas also triggers pro-inflammatory cytokine responses.Synonyms: APT1, Apo-1 antigen, FAS1, FASLG receptor, TNFRSF6, Tumor necrosis factor receptor superfamily member 6|
|Pathways||p53 Signaling, Apoptosis, TCR Signaling|
Application DetailsProduct Details anti-FAS Antibody Target Details FAS Handling References for anti-FAS Antibody (ABIN238438) Images back to top
Flow Cytometry. Immunohistochemistry (paraffin sections). Positive tissue: tonsil
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
|Restrictions||For Research Use only|
HandlingProduct Details anti-FAS Antibody Target Details FAS Application Details References for anti-FAS Antibody (ABIN238438) Images back to top
|Buffer||Tris buffered saline (TBS), pH 8.0, 15 mM Sodium Azide|
|Precaution of Use||This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Storage||4 °C/-20 °C|
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
|Expiry Date||12 months|
References for anti-FAS Antibody (ABIN238438)Product Details anti-FAS Antibody Target Details FAS Application Details Handling Images back to top
Brumatti, Yon, Castro et al.: "Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide." in: Experimental cell research, Vol. 314, Issue 3, pp. 554-63, 2008 (PubMed).
Guo, Zhang, Tang et al.: "Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines." in: Blood, Vol. 106, Issue 6, pp. 2033-41, 2005 (PubMed).
Drosopoulos, Roberts, Cermak et al.: "Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway." in: The Journal of biological chemistry, Vol. 280, Issue 24, pp. 22856-67, 2005 (PubMed).
Nakamura, Kakinuma, Amada et al.: "Pyrazole derivatives as new potent and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors." in: Bioorganic & medicinal chemistry, Vol. 12, Issue 23, pp. 6209-19, 2004 (PubMed).
Park, Thomsen, Frevert et al.: "Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 170, Issue 12, pp. 6209-16, 2003 (PubMed).
Scaffidi, Fulda, Srinivasan et al.: "Two CD95 (APO-1/Fas) signaling pathways." in: The EMBO journal, Vol. 17, Issue 6, pp. 1675-87, 1998 (PubMed).
ImagesProduct Details anti-FAS Antibody Target Details FAS Application Details Handling References for anti-FAS Antibody (ABIN238438) back to top